Aclaris Therapeutics shares owned by Wells Fargo & Company
Quarter-by-quarter ownership of Aclaris Therapeutics (ACRS) shares owned by Wells Fargo & Company
from 13F filings
Historical chart of Wells Fargo & Company investment in Aclaris Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aclaris Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Aclaris Therapeutics by Wells Fargo & Company
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $129k | 68k | 1.90 |
| 2025-06-30 | $89k | 63k | 1.42 |
| 2025-03-31 | $7.0k | 4.6k | 1.53 |
| 2024-12-31 | $11k | 4.6k | 2.48 |
| 2024-09-30 | $5.3k | 4.6k | 1.15 |
| 2024-06-30 | $5.0k | 4.6k | 1.10 |
| 2024-03-31 | $32k | 26k | 1.24 |
| 2023-12-31 | $21k | 20k | 1.05 |
| 2023-09-30 | $125k | 18k | 6.85 |
| 2023-06-30 | $334k | 32k | 10.37 |
| 2022-12-31 | $120k | 7.6k | 15.75 |
| 2022-09-30 | $95k | 6.1k | 15.54 |
| 2022-06-30 | $89k | 6.3k | 14.00 |
| 2022-03-31 | $685k | 40k | 17.21 |
| 2021-12-31 | $477k | 33k | 14.55 |
| 2021-09-30 | $2.2M | 121k | 18.00 |
| 2021-06-30 | $20k | 1.1k | 18.02 |
| 2021-03-31 | $35k | 1.4k | 25.00 |
| 2020-12-31 | $214k | 33k | 6.50 |
| 2020-09-30 | $5.6k | 1.2k | 4.61 |
| 2020-06-30 | $4.7k | 2.2k | 2.09 |
| 2020-03-31 | $54k | 52k | 1.03 |
| 2019-12-31 | $49k | 26k | 1.88 |
| 2019-09-30 | $35k | 32k | 1.08 |
| 2019-06-30 | $54k | 25k | 2.17 |
| 2019-03-31 | $184k | 31k | 6.01 |
| 2018-12-31 | $202k | 27k | 7.40 |
| 2018-09-30 | $229k | 16k | 14.52 |
| 2018-06-30 | $297k | 15k | 19.96 |
| 2018-03-31 | $268k | 15k | 17.50 |
| 2017-12-31 | $376k | 15k | 24.66 |
| 2017-06-30 | $1.1M | 41k | 27.11 |
| 2017-03-31 | $369k | 12k | 29.86 |
| 2016-12-31 | $175k | 6.5k | 27.09 |
| 2016-09-30 | $84k | 3.3k | 25.72 |
| 2016-06-30 | $30k | 1.6k | 18.19 |
| 2016-03-31 | $30k | 1.9k | 16.27 |
| 2015-12-31 | $45k | 1.7k | 27.11 |